7th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 19-21, 2026 | Boston, Massachusetts, USA
Endorphin System in Addiction
The endorphin system plays a vital role in regulating mood, pain, and emotional responses, and it is closely linked to the development of addiction. Endorphins are natural chemicals produced by the brain that interact with opioid receptors, helping to relieve pain and create feelings of well-being or euphoria. Addictive substances, such as alcohol, heroin, and other opioids, can artificially boost the release of endorphins, leading to intense pleasure and reinforcing the desire to continue using the substance. Over time, the brain becomes dependent on these external sources of endorphins, which can contribute to physical dependence and addiction. Understanding the endorphin system has led to treatments that target its function, including medications like naltrexone, which blocks opioid receptors and helps reduce cravings, aiding in long-term recovery from addiction.
Frederick J Goldstein
Philadelphia College of Osteopathic Medicine, United States
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
John Michael Weber
Trauma Healed Life Coach, United States
Denis Larrivee
University of Navarra, Spain
Steve Cohen
Medvesta Hypnosis Healthcare, United States
Andrew Drasen
A Vision of Hope Media, United StatesSubmit your abstract Today
Title : The storm within: Neuropsychological insights into dysregulation and substance use in the adolescent brain
Ann Marie Leonard Zabel, Curry College, United States
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : Trauma: Till death do us part
John Michael Weber, Trauma Healed Life Coach, United States
Title : Addiction and the failure of meaning-forming
Jenni Guentcheva, GTI, United States
Title : Beating the blues today
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Reduction of chronic neuropathic pain by a THC-CBD combination capsule: ongoing pilot study
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States